FindTrial
Sign In

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2010-020015-36-DE
Enrollment
Unknown
Registered
2011-02-07
Start date
2011-04-15
Completion date
Unknown
Last updated
2014-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes mellitus Type II MedDRA version: 13.1 Level: LLT Classification code 10045242 Term: Type II diabetes mellitus System Organ Class: 10027433 - Metabolism and nutrition disorders

Interventions

Trade Name: Januvia Pharmaceutical Form: Capsule INN or Proposed INN: SITAGLIPTIN CAS Number: 790712-60-6 Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 50- Pharma

Sponsors

Diabeteszentrum Bad Lauterberg
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: 0 F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 12 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 12

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):—

Countries

Germany

Contacts

Public ContactStudienzentrum

Diabeteszentrum Bad Lauterberg

baranov@diabeteszentrum.de0049552481265

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026